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Background Endoscopic mucosal resection (EMR) and endoscopic submucosal
dissection (ESD) are the first-line treatments for superficial esophageal squamous
cell carcinoma (SCC). This study aimed to compare long-term clinical outcome and
oncological clearance between EMR and ESD for the treatment of superficial
esophageal SCC.
Methods We conducted a retrospective multicenter study in five French tertiary care
hospitals. Patients treated by EMR or ESD for histologically proven superficial
esophageal SCC were included consecutively.
Results Resection was performed for 148 tumors (80 EMR, 68 ESD) in 132 patients.
The curative resection rate was 21.3 % in the EMR group and 73.5 % in the ESD
group (P < 0.001). The recurrence rate was 23.7 % in the EMR group and 2.9 % in the
ESD group (P = 0.002). The 5-year recurrence-free survival rate was 73.4 % in the
EMR group and 95.2 % in the ESD group (P = 0.002). Independent factors for cancer
recurrence were resection by EMR (hazard ratio [HR] 16.89, P = 0.01), tumor
infiltration depth ≥ m3 (HR 3.28, P = 0.02), no complementary treatment by
chemoradiotherapy (HR 7.04, P = 0.04), and no curative resection (HR 11.75,
P = 0.01). Risk of metastasis strongly increased in patients with tumor infiltration
depth ≥ m3, and without complementary chemoradiotherapy (P = 0.02).
Conclusion Endoscopic resection of superficial esophageal SCC was safe and
efficient. Because it was associated with an increased recurrence-free survival rate,
ESD should be preferred over EMR. For tumors with infiltration depths ≥ m3,
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